Cradle cap cream for babies and toddlers
Part of Skin clinical trials.
This study tests a special cream called TRIDERM D.S. on babies and toddlers (0 to 3 years old) with cradle cap or mild-to-moderate seborrheic dermatitis. The cream aims to normalize the skin and reduce flaking and redness, offering a gentle option for your child's skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 0 and 3 years old.
- Your child is generally healthy.
- Your child has cradle cap or mild-to-moderate seborrheic dermatitis (scaly, greasy patches on the scalp or skin).
- Your child has not used any medicated creams (like steroids, antifungals, or peeling agents) on the affected areas for at least 15 days before the study starts.
- You (as parent or guardian) must give written permission for your child to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new lotion for people with mild to moderate seborrheic dermatitis (a common skin condition causing red, scaly patches on the scalp, face, or chest). The study checks safety and how well the lotion works.
This study tests a new foam (roflumilast) applied to the skin to treat seborrheic dermatitis, a condition causing red, flaky patches usually on the scalp or face. It aims to see if the foam reduces redness and scaling better than a placebo.
This study tests a medical cream for people with atopic or contact dermatitis (eczema). It aims to see how well the cream works and if it is safe for both adults and children over 6 months old.
This study compares two creams for treating mild to moderate eczema in children: crisaborole 2% and tacrolimus 0.1%. It aims to see which one is more effective and safe for your child.
This study tests two different prescription creams, crisaborole and tacrolimus, to see which works better for treating eczema (also called atopic dermatitis) in people aged 5 to 25. If you or your child have mild to moderate eczema, this trial may help find a more effective treatment option.
This study compares using mother's breast milk against using a barrier cream to treat diaper rash in babies up to 24 months old. It aims to find which method works better for healing the rash.
Hear when a new Seborrheic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.